CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

Journal of Experimental Medicine

Volumn 208, Issue 13, 2011, Pages 2633-2640

  Chen, Zhangguo ^a   Chen, Lanfen ^a   Baker, Kristi ^a   Olszak, Torsten ^a   Zeissig, Sebastian ^a   Huang, Yu Hwa ^a   Kuo, Timothy T ^a   Mandelboim, Ofer ^b   Beauchemin, Nicole ^c   Lanier, Lewis L ^d   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HEBREW UNIVERSITY   (Israel)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOLYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; TUMOR ESCAPE;

EID: 84862908667     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102575     Document Type: Article

References (28)

1. Arapovic, J., T. Lenac, R. Antulov, B. Polic, Z. Ruzsics, L.N. Carayannopoulos, U.H. Koszinowski, A. Krmpotic, and S. Jonjic. 2009. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J. Virol. 83:8198-8207. http://dx.doi.org/10.1128/JVI.02549-08.
2. Champsaur, M.A., and L.L. Lanier. 2010. Effect of NKG2D ligand expression on host immune response. Immunol. Rev. 170:4196-4200. http://dx.doi.org/10.1111/j.0105-2896.2010.00893.x.
3. Chen, Z., L. Chen, S.W. Qiao, T. Nagaishi, and R.S. Blumberg. 2008. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70. J. Immunol. 180:6085-6093.
4. Coudert, J.D., and W. Held. 2006. The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 16:333-343. http://dx.doi.org/10.1016/j.semcancer.2006.07.008.
5. Dango, S., W. Sienel, M. Schreiber, C. Stremmel, A. Kirschbaum, K. Pantel, and B. Passlick. 2008. Elevated expression of carcinoembryonic antigenrelated cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Lung Cancer. 60:426-433. http://dx.doi.org/10.1016/j.lungcan.2007.11.015.
6. Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:165-171. http://dx.doi.org/10.1038/35093109.
7. Dveksler, G.S., M.N. Pensiero, C.W. Dieffenbach, C.B. Cardellichio, A.A. Basile, P.E. Elia, and K.V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA. 90:1716-1720. http://dx.doi.org/10.1073/pnas.90.5.1716.
8. Fuertes, M.B., M.V. Girart, L.L. Molinero, C.I. Domaica, L.E. Rossi, M.M. Barrio, J. Mordoh, G.A. Rabinovich, and N.W. Zwirner. 2008. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J. Immunol. 180:4606-4614.
9. Gambichler, T., S. Grothe, S. Rotterdam, P. Altmeyer, and A. Kreuter. 2009. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions. Am. J. Clin. Pathol. 131:782-787. http://dx.doi.org/10.1309/AJCP24KXJVBZXENS.
10. Gray-Owen, S.D., and R.S. Blumberg. 2006. CEACAM1: contactdependent control of immunity. Nat. Rev. Immunol. 6:433-446. http://dx.doi.org/10.1038/nri1864.
11. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 419:734-738. http://dx.doi.org/10.1038/nature01112.
12. Kang, W.Y., W.T. Chen, M.T. Wu, and C.Y. Chai. 2007. The expression of CD66a and possible roles in colorectal adenoma and adenocarcinoma. Int. J. Colorectal Dis. 22:869-874. http://dx.doi.org/10.1007/s00384-006-0247-x.
13. Lanier, L.L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9:495-502. http://dx.doi.org/10.1038/ni1581.
14. Leung, N., C. Turbide, M. Olson, V. Marcus, S. Jothy, and N. Beauchemin. 2006. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene. 25:5527-5536. http://dx.doi.org/10.1038/sj.onc.1209541.
15. Lim, Y.S., B.Y. Kang, E.J. Kim, S.H. Kim, S.Y. Hwang, and T.S. Kim. 1998. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs. Mol. Cells. 8:629-636.
16. Liu, W., W. Wei, D. Winer, A.M. Bamberger, C. Bamberger, C. Wagener, S. Ezzat, and S.L. Asa. 2007. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene. 26:2747-2758. http://dx.doi.org/10.1038/sj.onc.1210077.
17. Markel, G., N. Lieberman, G. Katz, T.I. Arnon, M. Lotem, O. Drize, R.S. Blumberg, E. Bar-Haim, R. Mader, L. Eisenbach, and O. Mandelboim. 2002. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 168:2803-2810.
18. Markel, G., R. Ortenberg, R. Seidman, S. Sapoznik, N. Koren-Morag, M.J. Besser, J. Bar, R. Shapira, A. Kubi, G. Nardini, et al. 2010. Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunol. Immunother. 59:215-230. http://dx.doi.org/10.1007/s00262-009-0740-5.
19. Morales, V.M., A. Christ, S.M. Watt, H.S. Kim, K.W. Johnson, N. Utku, A.M. Texieira, A. Mizoguchi, E. Mizoguchi, G.J. Russell, et al. 1999. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163:1363-1370.
20. Nakajima, A., H. Iijima, M.F. Neurath, T. Nagaishi, E.E. Nieuwenhuis, R. Raychowdhury, J. Glickman, D.M. Blau, S. Russell, K.V. Holmes, and R.S. Blumberg. 2002. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J. Immunol. 168:1028-1035.
21. Obrink, B. 2008. On the role of CEACAM1 in cancer. Lung Cancer. 60:309-312. http://dx.doi.org/10.1016/j.lungcan.2008.03.020.
22. Sienel, W., S. Dango, U. Woelfle, A. Morresi-Hauf, C. Wagener, J. Brümmer, W. Mutschler, B. Passlick, and K. Pantel. 2003. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer. Clin. Cancer Res. 9:2260-2266.
23. Simeone, D.M., B. Ji, M. Banerjee, T. Arumugam, D. Li, M.A. Anderson, A.M. Bamberger, J. Greenson, R.E. Brand, V. Ramachandran, and C.D. Logsdon. 2007. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas. 34:436-443. http://dx.doi.org/10.1097/MPA.0b013e3180333ae3.
24. Spies, T. 2008. Regulation of NKG2D ligands: a purposeful but delicate affair. Nat. Immunol. 9:1013-1015. http://dx.doi.org/10.1038/ni0908-1013.
25. Stern-Ginossar, N., N. Elefant, A. Zimmermann, D.G. Wolf, N. Saleh, M. Biton, E. Horwitz, Z. Prokocimer, M. Prichard, G. Hahn, et al. 2007. Host immune system gene targeting by a viral miRNA. Science. 317:376-381. http://dx.doi.org/10.1126/science.1140956.
26. Tilki, D., B.B. Singer, S.F. Shariat, A. Behrend, M. Fernando, S. Irmak, A. Buchner, A.T. Hooper, C.G. Stief, O. Reich, and S. Ergun. 2009. CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection. Eur. Urol. 15:501-509. http://dx.doi.org/10.1016/j.eururo.2009.05.040.
27. Wu, J., N.J. Chalupny, T.J. Manley, S.R. Riddell, D. Cosman, and T. Spies. 2003. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol. 170:4196-4200.
28. Xi, L., A. Feber, V. Gupta, M. Wu, A.D. Bergemann, R.J. Landreneau, V.R. Litle, A. Pennathur, J.D. Luketich, and T.E. Godfrey. 2008. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res. 36:6535-6547. http://dx.doi.org/10.1093/nar/gkn697.